Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial
Go back to Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial| (NASDAQ: ELDN) | Delayed: 2.97 -0.05 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $ | |||
| Open | $3.02 | 52 Week Low | $ | |||
| Day High | $3.03 | P/E | N/A | |||
| Day Low | $2.92 | EPS | $ | |||
| Volume | 529,487 | |||||
